Gastric cancer mesenchymal stem cells upregulate PD-1 expression on the CD8+ T cells by regulating the PI3K/AKT pathway
Molecular Immunology · 2025
DOI: 10.1016/j.molimm.2025.01.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Immunology, 2025. Verfasst von Weimeng Ji und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Digestive Diseases, Jiangsu University, Zhenjiang, Jiangsu 212001, China; Department of Oncology, Affiliated Hospital of Jiangsu Univers…. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Stomach Neoplasms, Programmed Cell Death 1 Receptor, CD8-Positive T-Lymphocytes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Research of Jiangsu Higher Education Institutions of China.
Abstract (Originalsprache)
Gastric cancer mesenchymal stem cells (GC-MSCs) are a crucial component of the gastric cancer microenvironment, exerting a pivotal influence on the formation of a suppressive immune microenvironment and the progression of gastric cancer. In this study, we utilized GC-MSCs to co-culture peripheral blood mononuclear cells (PBMCs) obtained from both gastric cancer patients and healthy individuals in a proportionate manner by direct cell-to-cell contact. Our findings reveal that co-culture of GC-MSCs with PBMCs led to a notable reduction in CD8+ T cells percentages and an increase in surface PD-1 expression levels on CD8+ T cells. However, flow cytometry analysis demonstrated no significant changes following pretreatment with GC-MSC-conditioned medium (GC-MSC-CM). Moreover, western blotting analysis demonstrated a notable reduction in phosphorylated AKT levels in co-cultured PBMCs. Collectively, our results suggest that GC-MSCs impair the anti-tumor immune response of PBMCs by elevating the PD-1 levels of CD8+ T cells and impairing the killing of CD8+ T cells. These findings provide new evidence that GC-MSCs contribute to immunosuppression within the tumor microenvironment (TME).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Digestive Diseases, Jiangsu University, Zhenjiang, Jiangsu 212001, China; Department of Oncology, Affiliated Hospital of Jiangsu University, Jiangsu University, Zhenjiang, Jiangsu 212001, China; School of M…
- Department of Laboratory Medicine, Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, Jiangsu, China.
- School of Medicine, Jiangsu University, 301 Xuefu Road, Zhenjiang, Jiangsu 212013, China.
- Department of Clinical Laboratory, Affiliated Kunshan Hospital of jiangsu University, Suzhou, Jiangsu 215399, China.
- Institute of Digestive Diseases, Jiangsu University, Zhenjiang, Jiangsu 212001, China; Department of Oncology, Affiliated Hospital of Jiangsu University, Jiangsu University, Zhenjiang, Jiangsu 212001, China. Electronic…
Förderung
- National Natural Science Foundation of China
- Natural Science Research of Jiangsu Higher Education Institutions of China
Zitieren
APA
Ji, W., Xu, J., Huang, C., Liu, T., Chen, S., Zhao, Y., Zhou, C., Sun, L., Wang, M., Wang, D., & Zhu, W. (2025). Gastric cancer mesenchymal stem cells upregulate PD-1 expression on the CD8+ T cells by regulating the PI3K/AKT pathway. Molecular Immunology. https://doi.org/10.1016/j.molimm.2025.01.005
Vancouver
Ji W, Xu J, Huang C, Liu T, Chen S, Zhao Y, et al. Gastric cancer mesenchymal stem cells upregulate PD-1 expression on the CD8+ T cells by regulating the PI3K/AKT pathway. Molecular Immunology. 2025. doi:10.1016/j.molimm.2025.01.005
BibTeX
@article{Ji2025,
author = {Ji, Weimeng and Xu, Juan and Huang, Chao and Liu, Ting and Chen, Shihan and Zhao, Yuanyuan and Zhou, Chenglin and Sun, Li and Wang, Mei and Wang, Deqiang and Zhu, Wei},
title = {Gastric cancer mesenchymal stem cells upregulate PD-1 expression on the CD8+ T cells by regulating the PI3K/AKT pathway},
journal = {Molecular Immunology},
year = {2025},
doi = {10.1016/j.molimm.2025.01.005}
}
EUVIMED